uniQure (QURE)
(Real Time Quote from BATS)
$5.91 USD
-0.31 (-4.98%)
Updated Aug 30, 2024 12:40 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Income Statements
Fiscal Year end for uniQure NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 16 | 106 | 524 | 38 | 7 |
Cost Of Goods | 14 | 2 | 0 | 0 | 0 |
Gross Profit | 2 | 104 | 524 | 38 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 285 | 248 | 213 | 163 | 128 |
Income After Depreciation & Amortization | -283 | -143 | 311 | -125 | -121 |
Non-Operating Income | 18 | 27 | 30 | -12 | 1 |
Interest Expense | 42 | 12 | 7 | 4 | 4 |
Pretax Income | -307 | -128 | 333 | -141 | -124 |
Income Taxes | 2 | -1 | 3 | -16 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -308 | -127 | 330 | -125 | -124 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -308 | -127 | 330 | -125 | -124 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -271 | -135 | 318 | -115 | -114 |
Depreciation & Amortization (Cash Flow) | 12 | 9 | 7 | 11 | 7 |
Income After Depreciation & Amortization | -283 | -143 | 311 | -125 | -121 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 47.67 | 46.74 | 46.84 | 44.47 | 40.00 |
Diluted EPS Before Non-Recurring Items | -6.47 | -2.71 | 7.04 | -2.81 | -3.11 |
Diluted Net EPS (GAAP) | -6.47 | -2.71 | 7.04 | -2.81 | -3.11 |
Fiscal Year end for uniQure NV falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 11.13 | 8.49 | 6.69 | 1.41 | 2.42 |
Cost Of Goods | 7.23 | 9.08 | 8.83 | 1.01 | 1.35 |
Gross Profit | 3.90 | -0.59 | -2.15 | 0.40 | 1.07 |
SG&A, R&D, and Dept/Amort Expenses | 47.91 | 53.64 | 59.60 | 82.28 | 66.15 |
Income After SG&A, R&D, and Dept/Amort Expenses | -44.01 | -54.23 | -61.75 | -81.88 | -65.08 |
Non-Operating Income | 4.82 | 5.36 | 7.29 | 7.68 | 3.60 |
Interest Expense | 16.16 | 16.10 | 15.71 | 15.44 | 6.84 |
Pretax Income | -55.35 | -64.96 | -70.17 | -89.64 | -68.31 |
Income Taxes | 0.95 | 0.66 | 3.03 | -0.07 | 0.16 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -56.30 | -65.62 | -73.21 | -89.57 | -68.47 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -56.30 | -65.62 | -73.21 | -89.57 | -68.47 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 48.62 | 48.39 | 47.85 | 47.77 | 47.65 |
Diluted EPS Before Non-Recurring Items | -1.16 | -1.36 | -1.53 | -1.88 | -1.44 |
Diluted Net EPS (GAAP) | -1.16 | -1.36 | -1.52 | -1.88 | -1.44 |